{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:32:17Z","timestamp":1773675137483,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Provincial and Ministerial Major Project of China","award":["110202001031(JY-14)"],"award-info":[{"award-number":["110202001031(JY-14)"]}]},{"name":"Provincial and Ministerial Major Project of China","award":["110202102014"],"award-info":[{"award-number":["110202102014"]}]},{"name":"Provincial and Ministerial Major Project of China","award":["552022AK0070"],"award-info":[{"award-number":["552022AK0070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12035-024-04040-8","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T07:02:11Z","timestamp":1709276531000},"page":"7692-7706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Nicotine Metabolic Rate on Nicotine Dependence and Rewarding: Nicotine Metabolism in Chinese Male Smokers and Male Mice"],"prefix":"10.1007","volume":"61","author":[{"given":"Mingda","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaning","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2560-2501","authenticated-orcid":false,"given":"Hongwei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"4040_CR1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/clpt.2008.3","volume":"83","author":"NL Benowitz","year":"2008","unstructured":"Benowitz NL (2008) Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83:531\u2013541","journal-title":"Clin Pharmacol Ther"},{"key":"4040_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fnins.2020.00513","volume":"14","author":"E Pimentel","year":"2020","unstructured":"Pimentel E, Sivalingam K, Doke M, Samikkannu T (2020) Effects of drugs of abuse on the blood-brain barrier: a brief overview. Front Neurosci 14:513","journal-title":"Front Neurosci"},{"key":"4040_CR3","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1073\/pnas.0909184107","volume":"107","author":"JE Rose","year":"2010","unstructured":"Rose JE, Mukhin AG, Lokitz SJ, Turkington TG, Herskovic J, Behm FM, Garg S, Garg PK (2010) Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine. Proc Natl Acad Sci USA 107:5190\u20135195","journal-title":"Proc Natl Acad Sci USA"},{"key":"4040_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-neuro-061010-113734","volume":"34","author":"M De Biasi","year":"2011","unstructured":"De Biasi M, Dani JA (2011) Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 34:105\u2013130","journal-title":"Annu Rev Neurosci"},{"key":"4040_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-319-13665-3_3","volume":"23","author":"J-A Tanner","year":"2015","unstructured":"Tanner J-A, Chenoweth MJ, Tyndale RF (2015) Pharmacogenetics of nicotine and associated smoking behaviors. Neurobiol Gen Nicot Tobacco 23:37\u201386","journal-title":"The Neurobiology and Genetics of Nicotine and Tobacco"},{"key":"4040_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/dmdi-2012-0001","volume":"27","author":"H Raunio","year":"2012","unstructured":"Raunio H, Rahnasto-Rilla M (2012) CYP2A6: genetics, structure, regulation, and function. Drug Metab Drug Interact 27:73\u201388","journal-title":"Drug Metab Drug Interact"},{"key":"4040_CR7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01677060802572887","volume":"23","author":"R Ray","year":"2009","unstructured":"Ray R, Tyndale RF, Lerman C (2009) Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet 23:252\u2013261","journal-title":"J Neurogenet"},{"key":"4040_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0169-409X(02)00065-0","volume":"54","author":"C Xu","year":"2002","unstructured":"Xu C, Goodz S, Sellers EM, Tyndale RF (2002) CYP2A6 genetic variation and potential consequences. Adv Drug Deliv Rev 54:1245\u20131256","journal-title":"Adv Drug Deliv Rev"},{"key":"4040_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12272-014-0348-y","volume":"38","author":"J-H Kim","year":"2015","unstructured":"Kim J-H, Cheong HS, Park BL, Kim LH, Shin HJ, Na HS, Chung MW, Shin HD (2015) Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations. Arch Pharmacal Res 38:115\u2013128","journal-title":"Arch Pharmacal Res"},{"key":"4040_CR10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s002040050005","volume":"73","author":"K Inoue","year":"2000","unstructured":"Inoue K, Yamazaki H, Shimada T (2000) CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Arch Toxicol 73:532\u2013539","journal-title":"Arch Toxicol"},{"key":"4040_CR11","first-page":"437","volume":"289","author":"KI Nunoya","year":"1999","unstructured":"Nunoya KI, Yokoi T, Kimura K, Kainuma T, Satoh K, Kinoshita M, Kamataki T (1999) A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans. J Pharmacol Exp Ther 289:437\u2013442","journal-title":"J Pharmacol Exp Ther"},{"key":"4040_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.0306-5251.2001.01500.x","volume":"52","author":"H Raunio","year":"2001","unstructured":"Raunio H, Rautio A, Gullst\u00e9n H, Pelkonen O (2001) Polymorphisms of CYP2A6 and its practical consequences. Br J Clin Pharmacol 52:357\u2013363","journal-title":"Br J Clin Pharmacol"},{"key":"4040_CR13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/00498250600715932","volume":"36","author":"M Nurfadhlina","year":"2006","unstructured":"Nurfadhlina M, Foong K, Teh L, Tan S, Zaki SM, Ismail R (2006) CYP2A6 polymorphisms in Malays, Chinese and Indians. Xenobiotica 36:684\u2013692","journal-title":"Xenobiotica"},{"key":"4040_CR14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.clpt.2006.05.012","volume":"80","author":"M Nakajima","year":"2006","unstructured":"Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL et al (2006) Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 80:282\u2013297","journal-title":"Clin Pharmacol Ther"},{"key":"4040_CR15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00008571-200409000-00006","volume":"14","author":"KA Schoedel","year":"2004","unstructured":"Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF (2004) Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 14:615\u2013626","journal-title":"Pharmacogenetics"},{"key":"4040_CR16","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1542\/peds.2006-1583","volume":"119","author":"J Audrain-McGovern","year":"2007","unstructured":"Audrain-McGovern J, Al Koudsi N, Rodriguez D, Wileyto EP, Shields PG, Tyndale RF (2007) The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 119:e264-274","journal-title":"Pediatrics"},{"key":"4040_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1183\/09031936.06.00056305","volume":"27","author":"N Minematsu","year":"2006","unstructured":"Minematsu N, Nakamura H, Furuuchi M, Nakajima T, Takahashi S, Tateno H, Ishizaka A (2006) Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms. Eur Respir J 27:289\u2013292","journal-title":"Eur Respir J"},{"key":"4040_CR18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.mp.4001794","volume":"11","author":"V Malaiyandi","year":"2006","unstructured":"Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF (2006) Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry 11:400\u2013409","journal-title":"Mol Psychiatry"},{"key":"4040_CR19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00228-004-0854-9","volume":"60","author":"MA Gyamfi","year":"2005","unstructured":"Gyamfi MA, Fujieda M, Kiyotani K, Yamazaki H, Kamataki T (2005) High prevalence of cytochrome P 450 2A6* 1A alleles in a black African population of Ghana. Eur J Clin Pharmacol 60:855\u2013857","journal-title":"Eur J Clin Pharmacol"},{"key":"4040_CR20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1360-0443.2010.03353.x","volume":"106","author":"T Liu","year":"2011","unstructured":"Liu T, David SP, Tyndale RF, Wang H, Zhou Q, Ding P, He YH, Yu XQ et al (2011) Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction 106:985\u2013994","journal-title":"Addiction"},{"key":"4040_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(99)00359-2","volume":"448","author":"M Oscarson","year":"1999","unstructured":"Oscarson M, McLellan RA, Gullst\u00e9n H, Yue QY, Lang MA, Bernal ML, Sinues B, Hirvonen A et al (1999) Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett 448:105\u2013110","journal-title":"FEBS Lett"},{"key":"4040_CR22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng.573","volume":"42","author":"TE Thorgeirsson","year":"2010","unstructured":"Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T et al (2010) Sequence variants at CHRNB3\u2013CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42:448\u2013453","journal-title":"Nat Genet"},{"key":"4040_CR23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ntr\/ntab175","volume":"24","author":"SK Jones","year":"2022","unstructured":"Jones SK, Wolf BJ, Froeliger B, Wallace K, Carpenter MJ, Alberg AJ (2022) Nicotine metabolism predicted by CYP2A6 genotypes in relation to smoking cessation: a systematic review. Nicotine Tob Res 24:633\u2013642","journal-title":"Nicotine Tob Res"},{"key":"4040_CR24","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1542\/peds.2007-3679","volume":"122","author":"ML Rubinstein","year":"2008","unstructured":"Rubinstein ML, Benowitz NL, Auerback GM, Moscicki A-B (2008) Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics 122:e643\u2013e647","journal-title":"Pediatrics"},{"key":"4040_CR25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","volume":"79","author":"C Lerman","year":"2006","unstructured":"Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N (2006) Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther 79:600\u2013608","journal-title":"Clin Pharmacol Ther"},{"key":"4040_CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.addbeh.2015.07.019","volume":"51","author":"A Kaufmann","year":"2015","unstructured":"Kaufmann A, Hitsman B, Goelz PM, Veluz-Wilkins A, Blazekovic S, Powers L, Leone FT, Gariti P et al (2015) Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers. Addict Behav 51:93\u201399","journal-title":"Addict Behav"},{"key":"4040_CR27","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ntr\/ntv228","volume":"18","author":"JA Kulak","year":"2016","unstructured":"Kulak JA, Cornelius ME, Fong GT, Giovino GA (2016) Differences in quit attempts and cigarette smoking abstinence between whites and African Americans in the United States: literature review and results from the International Tobacco Control US Survey. Nicotine Tob Res 18:S79\u2013S87","journal-title":"Nicotine Tob Res"},{"key":"4040_CR28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yexmp.2014.10.012","volume":"97","author":"JH Liu","year":"2014","unstructured":"Liu JH, Xun XJ, Pang C, Ma J, Zou H, Chen C, Dai PG (2014) Single tube genotyping of CYP2A6 gene deletion based on copy number determination by quantitative real-time PCR. Exp Mol Pathol 97:529\u2013534","journal-title":"Exp Mol Pathol"},{"key":"4040_CR29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/FPC.0b013e32835f834d","volume":"23","author":"MJ Chenoweth","year":"2013","unstructured":"Chenoweth MJ, O\u2019Loughlin J, Sylvestre MP, Tyndale RF (2013) CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. Pharmacogenet Genomics 23:232\u2013235","journal-title":"Pharmacogenet Genomics"},{"key":"4040_CR30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cpt.1238","volume":"105","author":"E Liakoni","year":"2019","unstructured":"Liakoni E, Edwards KC, St Helen G, Nardone N, Dempsey DA, Tyndale RF, Benowitz NL (2019) Effects of nicotine metabolic rate on withdrawal symptoms and response to cigarette smoking after abstinence. Clin Pharmacol Ther 105:641\u2013651","journal-title":"Clin Pharmacol Ther"},{"key":"4040_CR31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41366-018-0037-x","volume":"43","author":"K Wang","year":"2005","unstructured":"Wang K, Chen X, Ward SC, Liu Y, Ouedraogo Y, Xu C, Cederbaum AI (2005) Lu Y (2019) CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. Int J Obes 43:475\u2013486","journal-title":"Int J Obes"},{"key":"4040_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ntr\/ntt105","volume":"16","author":"SD Alsharari","year":"2013","unstructured":"Alsharari SD, Siu ECK, Tyndale RF, Damaj MI (2013) Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5\/6 inhibitor. Nicotine Tob Res 16:18\u201325","journal-title":"Nicotine Tob Res"},{"key":"4040_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2014.05.006","volume":"85","author":"D Bagdas","year":"2014","unstructured":"Bagdas D, Muldoon PP, Zhu AZ, Tyndale RF, Damaj MI (2014) Effects of methoxsalen, a CYP2A5\/6 inhibitor, on nicotine dependence behaviors in mice. Neuropharmacology 85:67\u201372","journal-title":"Neuropharmacology"},{"key":"4040_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/pharmrev.121.000299","volume":"74","author":"L Wills","year":"2022","unstructured":"Wills L, Ables JL, Braunscheidel KM, Caligiuri SPB, Elayouby KS, Fillinger C, Ishikawa M, Moen JK et al (2022) Neurobiological mechanisms of nicotine reward and aversion. Pharmacol Rev 74:271\u2013310","journal-title":"Pharmacol Rev"},{"key":"4040_CR35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neubiorev.2011.06.007","volume":"36","author":"HJ Aubin","year":"2012","unstructured":"Aubin HJ, Rollema H, Svensson TH, Winterer G (2012) Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev 36:271\u2013284","journal-title":"Neurosci Biobehav Rev"},{"key":"4040_CR36","doi-asserted-by":"crossref","first-page":"1058254","DOI":"10.3389\/fnins.2022.1058254","volume":"16","author":"G Liu","year":"2022","unstructured":"Liu G, Wang R, Chen H, Wu P, Fu Y, Li K, Liu M, Shi Z et al (2022) Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition. Front Neurosci 16:1058254","journal-title":"Front Neurosci"},{"key":"4040_CR37","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41592-020-00981-9","volume":"17","author":"F Sun","year":"2020","unstructured":"Sun F, Zhou J, Dai B, Qian T, Zeng J, Li X, Zhuo Y, Zhang Y et al (2020) Next-generation GRAB sensors for monitoring dopaminergic activity in vivo. Nat Methods 17:1156\u20131166","journal-title":"Nat Methods"},{"key":"4040_CR38","doi-asserted-by":"crossref","unstructured":"Fu Y, Li X, Zhang S, Chen H, Wang H, Han S, Tian Y, Liu T, et al. (2022) A self-administered questionnaire to measure Chinese smokers\u2019 cigarette dependence. J Ethn Subst Abuse: 1\u201317","DOI":"10.1080\/15332640.2022.2149938"},{"key":"4040_CR39","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1021\/bi00246a023","volume":"30","author":"K Aida","year":"1991","unstructured":"Aida K, Negishi M (1991) Posttranscriptional regulation of coumarin 7-hydroxylase induction by xenobiotics in mouse liver: mRNA stabilization by pyrazole. Biochemistry 30:8041\u20138045","journal-title":"Biochemistry"},{"key":"4040_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/hep.21241","volume":"44","author":"Y Lu","year":"2006","unstructured":"Lu Y, Cederbaum AI (2006) Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: role of cytochrome P450 2E1 and 2A5. Hepatolog 44:263\u2013274","journal-title":"Hepatolog"},{"issue":"Pt 1","key":"4040_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj2860289","volume":"286","author":"B Hahnemann","year":"1992","unstructured":"Hahnemann B, Salonp\u00e4\u00e4 P, Pasanen M, M\u00e4enp\u00e4\u00e4 J, Honkakoski P, Juvonen R, Lang MA, Pelkonen O et al (1992) Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a\u20134\/5 (Cyp2a-4\/5) expression. Biochem J 286(Pt 1):289\u2013294","journal-title":"Biochem J"},{"key":"4040_CR42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14622200801901880","volume":"10","author":"MD Blank","year":"2008","unstructured":"Blank MD, Sams C, Weaver MF, Eissenberg T (2008) Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res 10:417\u2013421","journal-title":"Nicotine Tob Res"},{"key":"4040_CR43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","volume":"3","author":"LS Cox","year":"2001","unstructured":"Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7\u201316","journal-title":"Nicotine Tob Res"},{"key":"4040_CR44","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr\u00f6m KO (1991) The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire. Br J Addict 86:1119\u20131127","journal-title":"Br J Addict"},{"key":"4040_CR45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ntr\/ntp083","volume":"11","author":"MD Blank","year":"2009","unstructured":"Blank MD, Disharoon S, Eissenberg T (2009) Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res 11:896\u2013903","journal-title":"Nicotine Tob Res"},{"key":"4040_CR46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ntr\/ntr150","volume":"14","author":"KA Perkins","year":"2012","unstructured":"Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA (2012) The reliability of puff topography and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res 14:490\u2013494","journal-title":"Nicotine Tob Res"},{"key":"4040_CR47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/jpet.106.111237","volume":"320","author":"MI Damaj","year":"2007","unstructured":"Damaj MI, Siu EC, Sellers EM, Tyndale RF, Martin BR (2007) Inhibition of nicotine metabolism by methoxysalen: pharmacokinetic and pharmacological studies in mice. J Pharmacol Exp Ther 320:250\u2013257","journal-title":"J Pharmacol Exp Ther"},{"key":"4040_CR48","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.neuron.2022.07.003","volume":"110","author":"C Liu","year":"2022","unstructured":"Liu C, Tose AJ, Verharen JP, Zhu Y, Tang LW, de Jong JW, Du JX, Beier KT et al (2022) An inhibitory brainstem input to dopamine neurons encodes nicotine aversion. Neuron 110:3018\u20133035","journal-title":"Neuron"},{"key":"4040_CR49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.107.121616","volume":"322","author":"D Kota","year":"2007","unstructured":"Kota D, Martin BR, Robinson SE, Damaj MI (2007) Nicotine dependence and reward differ between adolescent and adult male mice. J Pharmacol Exp Ther 322:399\u2013407","journal-title":"J Pharmacol Exp Ther"},{"key":"4040_CR50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.107.132977","volume":"325","author":"KJ Jackson","year":"2008","unstructured":"Jackson KJ, Martin BR, Changeux J-P, Damaj MI (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325:302\u2013312","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"4040_CR51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/dta.3363","volume":"15","author":"S Han","year":"2022","unstructured":"Han S, Liu C, Chen H, Fu Y, Zhang Y, Miao R, Ren P, Yu P et al (2022) Pharmacokinetics of freebase nicotine and nicotine salts following subcutaneous administration in male rats. Drug Test Anal 15(10):1099\u20131106","journal-title":"Drug Test Anal"},{"key":"4040_CR52","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/carcin\/bgh258","volume":"25","author":"M Fujieda","year":"2004","unstructured":"Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, Dosaka-Akita H, Sawamura Y et al (2004) Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 25:2451\u20132458","journal-title":"Carcinogenesis"},{"key":"4040_CR53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.addbeh.2010.03.004","volume":"35","author":"CE Sartor","year":"2010","unstructured":"Sartor CE, Lessov-Schlaggar CN, Scherrer JF, Bucholz KK, Madden PA, Pergadia ML, Grant JD, Jacob T et al (2010) Initial response to cigarettes predicts rate of progression to regular smoking: findings from an offspring-of-twins design. Addict Behav 35:771\u2013778","journal-title":"Addict Behav"},{"issue":"Pt B","key":"4040_CR54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.09.008","volume":"76","author":"CD Fowler","year":"2014","unstructured":"Fowler CD, Kenny PJ (2014) Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology 76(Pt B):533\u2013544","journal-title":"Neuropharmacology"},{"key":"4040_CR55","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1038\/npp.2015.131","volume":"40","author":"KP Jensen","year":"2015","unstructured":"Jensen KP, DeVito EE, Herman AI, Valentine GW, Gelernter J, Sofuoglu M (2015) A CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans. Neuropsychopharmacology 40:2813\u20132821","journal-title":"Neuropsychopharmacology"},{"key":"4040_CR56","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.113.208256","volume":"347","author":"L Li","year":"2013","unstructured":"Li L, Jia K, Zhou X, McCallum SE, Hough LB, Ding X (2013) Impact of nicotine metabolism on nicotine\u2019s pharmacological effects and behavioral responses: insights from a Cyp2a(4\/5)bgs-null mouse. J Pharmacol Exp Ther 347:746\u2013754","journal-title":"J Pharmacol Exp Ther"},{"key":"4040_CR57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/dmd.112.048736","volume":"41","author":"Y Wei","year":"2013","unstructured":"Wei Y, Li L, Zhou X, Zhang QY, Dunbar A, Liu F, Kluetzman K, Yang W et al (2013) Generation and characterization of a novel Cyp2a(4\/5)bgs-null mouse model. Drug Metab Dispos 41:132\u2013140","journal-title":"Drug Metab Dispos"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04040-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:21:59Z","timestamp":1726824119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04040-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04040-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval of human study was from Zhengzhou University.Ethics committee of Drug Clinical Trials (Approval Number: 2021\u201306-01). All the animal procedures were approved by the Laboratory Animal Management and Ethics Committee of China National Tobacco Quality Supervision and Test Center (Approval Number: CTQTC-SYXK-2021002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants and authors involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"We confirm that consent to publish has been received from all participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}